- AU$223.99m
- AU$210.27m
- AU$0.59m
Annual balance sheet for Race Oncology, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.989 | 1.73 | 9.32 | 33.5 | 21.5 |
| Net Total Receivables | 0.001 | 0.049 | 0.128 | 0.062 | 1.7 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1.02 | 2 | 10.6 | 34.2 | 23.5 |
| Net Intangible Assets | |||||
| Total Assets | 5.24 | 5.93 | 14.2 | 37.5 | 26.6 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.192 | 0.244 | 0.523 | 1.42 | 1.15 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.192 | 0.244 | 0.523 | 1.42 | 1.15 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 5.05 | 5.69 | 13.7 | 36.1 | 25.5 |
| Total Liabilities & Shareholders' Equity | 5.24 | 5.93 | 14.2 | 37.5 | 26.6 |
| Total Common Shares Outstanding |